Starpharma Holdings Ltd
ASX:SPL
Starpharma Holdings Ltd
ASX:SPL
Price:
0.12 AUD
Market Closed
Updated:
May 5, 2024
Starpharma Holdings Ltd
Operating Income
|
Starpharma Holdings Ltd
Operating Income Peer Comparison
Comparables:
MYX
NEU
BOT
PBP
C
CU6
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Starpharma Holdings Ltd
ASX:SPL
|
Operating Income
-AU$8.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Operating Income
-AU$165.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Operating Income
AU$204.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
102%
|
CAGR 10-Years
N/A
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Operating Income
-AU$18.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-28%
|
|
|
Probiotec Ltd
ASX:PBP
|
Operating Income
AU$20m
|
CAGR 3-Years
31%
|
CAGR 5-Years
24%
|
CAGR 10-Years
30%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Operating Income
-AU$26.4m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Starpharma Holdings Ltd's Operating Income?
Operating Income
-8.4m
AUD
-8.4m
AUD
Based on the financial report for Dec 31, 2023, Starpharma Holdings Ltd's Operating Income amounts to -8.4m AUD.
What is Starpharma Holdings Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
1%
1%
Over the last year, the Operating Income growth was 48%. The average annual Operating Income growth rates for Starpharma Holdings Ltd have been 24% over the past three years , 6% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
